Aniracetam

Introduced 1978

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published November 24, 2025•Updated November 24, 2025•Reviewed November 24, 2025

Clinical summary for Aniracetam: Aniracetam is a “nootropic” medicine used in some countries (but not the United States) for memory and thinking problems in older adults, such as dementia or blood vessel–related cognitive issues. In those patients, a dose around 1,500 mg per day has shown modest improvements on memory and thinking tests after several months. It is sometimes marketed online as a brain booster for healthy people, but high-quality studies in healthy adults are lacking. Common side effects in studies include nausea, headache, nervousness, and trouble sleeping. Product quality can vary widely when bought as a supplement because there is no FDA approval or standardization.

What It's Used For

Primary Indications

Cognitive impairment and attention/memory disorders of degenerative or vascular origin in older adults (approved in some countries).Symptomatic treatment of mild-to-moderate dementia or vascular cognitive impairment where no disease-modifying options are available.

Off-Label Uses

Experimental use as a nootropic for cognitive enhancement in otherwise healthy adults (evidence limited and inconsistent).Exploratory use for anxiety symptoms or mood augmentation in selected patients in some small studies and case series.

Patient-Friendly Explanation

In medical settings, aniracetam has mainly been studied and used for memory and thinking problems in older adults with dementia or blood vessel–related brain disease. Its use as a general ‘smart drug’ in healthy people is based mostly on theory and limited data, not on large, high-quality trials.

What People Notice

Reports from clinical studies in older adults and smaller experimental studies, plus real-world user reports, suggest the following patterns. Individual responses vary and many people notice little or no effect:

Cognitive Changes

"I felt a bit more mentally ‘awake’ and engaged during conversations."

How Fast It Works

Aniracetam’s parent compound has a short half-life, but some of its metabolites persist longer and may drive clinical effects.

Acute effects

Some users and small studies report changes in alertness, attention, or mood within hours of a dose.

Short-term course

In dementia and vascular cognitive impairment trials, measurable improvements typically appeared over weeks, with clearer separation from placebo at 4–6 months of continued treatment.

Duration

Despite rapid clearance of the parent drug (~30 minutes), accumulation of active metabolites with repeated dosing may underlie more sustained effects.

Offset

When discontinued after long-term use, effects on cognition generally fade over days to weeks as underlying disease processes continue.

How Well It Works

Cognitive test improvement at 6 months (elderly patients)

vs Superior to piracetam on 8/18 tests; superior to placebo on all tests

Active

44%

Placebo

Superior to piracetam on 8/18 tests; superior to placebo on all tests

In older adults with dementia or vascular cognitive problems, aniracetam helped people perform a bit better on memory and thinking tests after several months of treatment. It did better than placebo and somewhat better than another nootropic (piracetam) on several tests. These benefits were modest—not a dramatic cure—and there is no strong research showing similar benefits in healthy people.

Warnings & Limitations ⚠️

→If you live in a country where aniracetam is not an approved medicine, be especially cautious about buying it online—quality, dose, and safety can be uncertain.
→Do not expect dramatic improvements in memory or intelligence, especially if you are otherwise healthy. The best evidence is in older adults who already have cognitive problems, and even there the effects are modest.
→Take doses earlier in the day with food to reduce the chance of insomnia and stomach upset.
→Stop and seek medical advice if you have new or severe headaches, agitation, mood changes, or neurologic symptoms such as unusual movements or seizures.
→Use aniracetam only under the guidance of a qualified clinician if you have a neurologic or psychiatric diagnosis.

Side Effects

Generally mild in clinical trials, with gastrointestinal and CNS activation symptoms most common.

Common Things People Notice

Nausea or upset stomach
Headache
Nervousness, restlessness, or feeling ‘wired’
Trouble falling or staying asleep
Less commonly: dizziness or skin rash

Common Side Effects

Common

Nausea / gastrointestinal discomfort— Often mild and may improve when taken with food or when the dose is divided.

Common

Headache— Some users report headaches, occasionally when combining aniracetam with other nootropics or cholinergic supplements.

Common

Insomnia / difficulty sleeping— More likely if taken later in the day; taking the last dose earlier may help.

Common

Nervousness, agitation, or mild anxiety— A subset of patients report feeling more keyed-up or restless rather than calm.

⚠️ Serious Side Effects

Rare hypersensitivity reactions (widespread rash, swelling, trouble breathing).
Theoretical risk of seizure in susceptible individuals.
Worsening agitation, anxiety, or mood instability in patients with underlying psychiatric disorders.

Drug & Supplement Interactions

With: CNS stimulants (e.g., amphetamines, methylphenidate, modafinil, high-dose caffeine)

Risk: Additive CNS stimulation with increased nervousness, insomnia, palpitations, or anxiety.

Action: Use together cautiously, if at all. Start with low doses and monitor for over-stimulation and sleep disturbance.

With: Cholinergic drugs and supplements (e.g., donepezil, rivastigmine, galantamine, high-dose choline or alpha-GPC)

Risk: Potential additive cholinergic effects (headache, GI upset, muscle cramps).

Action: Monitor for cholinergic side effects; dose adjustments of one or both agents may be needed.

With: Other racetams or experimental nootropics

Risk: Uncertain; combined mechanisms may lead to unpredictable CNS effects.

Action: Avoid complex nootropic ‘stacks’ without clinical supervision; introduce one agent at a time and monitor carefully.

With: Antiepileptic drugs

Risk: Theoretical interactions at glutamatergic synapses; clinical significance unclear.

Action: Use only under specialist guidance in patients with seizure disorders; monitor seizure control.

Dosing & Administration

Adult Dosing

start: 750 mg by mouth twice daily with food (typical regimen in dementia/vascular cognitive impairment studies).

titrate: Adjust dose based on clinical response and tolerability; some protocols use 750 mg three times daily for a total of 2,250 mg/day.

usual range: 1,500 mg/day in divided doses (e.g., 750 mg BID).

max: Up to 3,000 mg/day has been used in some clinical settings, but higher doses increase the risk of CNS and GI side effects.

Patient-Friendly Explanation

In studies of older adults with memory and thinking problems, aniracetam is usually taken as 750 mg twice daily with meals, for a total of 1,500 mg a day. Your prescriber may start lower and adjust the dose slowly based on benefits and side effects.

Available Forms

Granules/sachets: 750 mg, 1,500 mg (varies by country and manufacturer).
Tablets: 750 mg.
Capsules: commonly 250 mg, 400 mg, or 750 mg strengths in various markets.

How It Works 🧠

Aniracetam is thought to act primarily as a positive allosteric modulator of AMPA-type glutamate receptors, enhancing fast excitatory neurotransmission in cortical and hippocampal circuits. It also appears to facilitate cholinergic signaling and influence dopaminergic and serotonergic pathways indirectly. In animal models, aniracetam and several of its metabolites enhance long-term potentiation and improve performance on learning and memory tasks, as well as showing anxiolytic-like effects in some paradigms.

Patient-Friendly Explanation

Aniracetam seems to ‘tune’ certain brain receptors that use glutamate (an important brain signal chemical) and also supports the system that uses acetylcholine, which is important for memory and attention. In animal studies and some human studies with dementia, this appears to help with learning and memory tasks, although the effects are usually modest.

Monitoring

Cognitive performance using brief screening tools or more detailed neuropsychological tests in patients treated for dementia or vascular cognitive impairment.
Activities of daily living and caregiver reports of memory, attention, and behavior.
Mood and anxiety symptoms, particularly if aniracetam is used in patients with underlying psychiatric conditions.
Sleep quality and presence of insomnia, particularly with afternoon or evening dosing.
Adverse effects including headache, nausea, nervousness, and rash.
Renal and hepatic function in patients with known impairment or on long-term, higher-dose therapy (expert opinion–based).

Special Populations

👶Pregnancy

Safety in pregnancy has not been established. Because it is not an essential or life-saving therapy and safer alternatives exist for most indications, aniracetam is generally avoided during pregnancy unless potential benefits clearly outweigh potential risks.

🤱Breastfeeding

It is unknown whether aniracetam or its metabolites are excreted into human breast milk. Given the lack of data and the availability of alternative treatments, avoidance during breastfeeding is usually recommended; if used, monitor the infant for sedation, irritability, feeding problems, or poor weight gain.

👧Children & Adolescents (Under 18)

Safety and efficacy have not been established in children or adolescents. Aniracetam is generally not recommended outside of research settings in this population.

👴Older Adults (65+)

Most clinical data are in older adults with cognitive impairment. While aniracetam has generally been well tolerated in these trials, increased sensitivity to CNS effects (insomnia, agitation, headaches) is possible; start at the lower end of the dosing range and titrate cautiously.

Stopping Aniracetam

No formal withdrawal syndrome has been described with aniracetam, and abrupt discontinuation is not generally associated with physiologic dependence. However, in long-term users—particularly those taking it for subjective cognitive or mood benefits—gradual discontinuation over several days to a couple of weeks can help distinguish true symptom recurrence from discontinuation effects and can provide an opportunity to monitor for mood or cognitive changes.

Patient-Friendly Explanation

You usually do not need a long taper when stopping aniracetam, but if you have been taking it for months or years, your clinician may suggest slowly lowering the dose over several days or weeks. This makes it easier to notice whether symptoms are returning and to watch for any change in mood or thinking.

Clinical Pearls ✨

Evidence of benefit is strongest for older adults with degenerative or vascular cognitive impairment, not for healthy individuals seeking broad cognitive enhancement.
Effect sizes in dementia and vascular cognitive trials are modest and should be framed realistically for patients and families.
Because aniracetam is not FDA-approved and supplement-grade products vary in quality, prescribing (where legal) or recommending pharmacy-grade preparations can reduce variability.
Given its AMPA-modulating and pro-cognitive profile, aniracetam is of mechanistic interest, but it should not displace better-supported interventions such as cholinesterase inhibitors, memantine, vascular risk factor control, and non-pharmacologic cognitive support.
When patients self-initiate aniracetam or other racetams from online sources, clinicians can provide harm-reduction counseling, clarify the limits of evidence, and help monitor for adverse effects rather than simply endorsing or condemning use.

Frequently Asked Questions

What is Aniracetam used for?

In some countries, aniracetam is prescribed for cognitive impairment in older adults, particularly memory and attention problems related to degenerative or vascular brain disease. In other places, including the United States, it is not approved but is sometimes used experimentally or as a supplement for cognitive or mood enhancement.

Is Aniracetam approved in the United States?

No. Aniracetam is not approved by the U.S. Food and Drug Administration (FDA) and is not available as a prescription medication in the United States. Products sold online are typically unregulated supplements with variable quality.

What dose of Aniracetam is used in clinical studies?

Most clinical trials in older patients with cognitive impairment used 1,500 mg per day in divided doses, commonly given as 750 mg twice daily with meals. Some protocols used slightly higher or lower doses depending on tolerability.

How long does it take for Aniracetam to work?

Some people report subjective changes in focus or mood within hours or days. In controlled trials with older adults who had cognitive impairment, clearer benefits generally appeared after several weeks, with the largest differences from placebo seen after 4–6 months of continuous treatment.

Is there good evidence that Aniracetam improves cognition in healthy adults?

No. Most studies involve older adults with dementia or vascular cognitive impairment. Animal work and isolated human experiments do not provide strong, consistent evidence that aniracetam produces meaningful cognitive enhancement in otherwise healthy adults.

What are the common side effects of Aniracetam?

The most commonly reported side effects in clinical studies are nausea or stomach upset, headache, insomnia, and feelings of nervousness or agitation. Less common side effects include dizziness and rash. Serious reactions appear to be rare but are not well characterized.

Do I need to taper Aniracetam when stopping it?

A specific withdrawal syndrome has not been described, so a long taper is usually not necessary. However, if you have been taking aniracetam for a long time, your clinician may suggest reducing the dose gradually over several days or weeks to monitor for symptom changes and make the transition more comfortable.

Can Aniracetam be combined with choline supplements?

Some users combine aniracetam with choline or other cholinergic supplements in an effort to improve benefits or reduce headaches, but this strategy has not been rigorously tested in clinical trials. If these are combined, it is important to monitor for headache, nausea, or other side effects and to discuss all supplements with a clinician.

This medication information is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Never take medication without a prescription from a licensed healthcare provider.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists

Aniracetam

Introduced 1978

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published November 24, 2025•Updated November 24, 2025•Reviewed November 24, 2025